Morgan Stanley’s Positive Outlook on Petrochemical Majors

Morgan Stanley has highlighted three Japanese petrochemical companies—Sumitomo Chemical (ticker 4005), Mitsui Chemicals (4183), and Asahi Kasei (3407)—as attractive investment opportunities, assigning each an overweight rating despite ongoing sector challenges. The firm notes that while overall demand remains weak and ethylene utilization rates are low, several tailwinds are emerging. China’s anti‑involution policies and indications of naphtha‑cracker downsizing in South Korea are improving market sentiment, and the firm expects Asian petrochemical prices and spreads to remain stable rather than decline further. Recent price spikes linked to Middle‑East developments have added volatility, but investment indicators stay low and shares appear generally undervalued, offering potential upside. Industry reorganisation is gaining momentum, which could further support the sector.

Company‑Specific Details

  • Sumitomo Chemical: Rated overweight, with a strategic emphasis on accelerating growth in agro‑chemicals and IT‑related sectors. Morgan Stanley points to a V‑shaped earnings recovery in its pharmaceutical subsidiary and praises its resource‑allocation strategy. The company reported a net loss of ¥311.8 billion for fiscal year 2023 and announced a global workforce reduction of 4,000 jobs. Following these results, Mizuho Securities downgraded Sumitomo’s rating from “Buy” to “Neutral”.
  • Mitsui Chemicals: Also given an overweight rating, positioned to benefit from the improving industry environment. Mitsui posted a 45.4% decline in net profit for the fiscal year ending March 2024. It announced a new partnership with Teijin to develop and market biomass‑derived plastics, signalling a move toward sustainable product lines.
  • Asahi Kasei: The third company in the trio, Asahi Kasei, received an overweight rating as well. Morgan Stanley expects the firm to gain from the sector’s valuation appeal and strengthening fundamentals, although specific financial figures were not disclosed.

Additional Context

The article notes that the analysis was generated with AI assistance and reviewed by an editor. No further regulatory or compliance actions were mentioned.